Product code GQX— Microbiology
ENZYGNOST ANTI-VZV IGG TEST
- Classification name
- Antiserum, Cf, Varicella-Zoster
- Device class
- Class 2
- Regulation
- 21 CFR 866.3900
- Advisory panel
- Microbiology
- Total cleared
- 11
- First cleared
- Most recent
Market context for product code GQX
FDA has cleared devices under product code GQX between 1977 and 1996, filed by 9 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.
Clearances per year
- 1996
- 1991
- 1989
- 1988
- 1987
- 1986
- 1985
- 1984
- 1977
Top applicants under product code GQX
Recent clearances under product code GQX
- K951799 — VARICELLA-ZOSTER VIRUS DIRECT IMMUNOFLUORESCENCE ASSAY
- K911301 — VZV IGM TEST
- K883427 — VIRGO(R) VZV-IGG ELISA
- K875358 — VZV TEST
- K863317 — ENZYGNOST ANTI-VZV IGG TEST
- K853540 — FIAX TEST KIT FOR VARICELLA ANTIBODY SEROLOGY
- K852930 — VARICELLA-ZOSTER-COMPLE FIX ANTIGEN AND NEG CONTRO
- K842096 — GLB VARICELLA-ZOSTER VIRUS FLUORESCENT
- K841526 — ORTHO VARICELLA-ZOSTER VIRUS IDENT.
- K770806 — VARICELLA-ZOSTER FA LABELLED (8-321 RF)
- K770810 — VARICELLA-ZOSTER FA LABELED PRESERUM
Data sourced from openFDA. This site is unofficial and independent of the FDA.